POLIOVIRUS VACCINE LIVE (ORIMUNE)

Course overview

Poliovirus vaccine live (OPV) is U.S. FDA-approved for prevention of acute poliomyelitis in persons ≥ 6 weeks. This continuing education module is designed to give the reader/learner an increased understanding of OPV. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.